Imagen de Portada
Código QR

How to get your high-risk patients to the new NCEP goals.

Now that the optimal LDL-cholesterol level for patients with coronary heart disease or its risk equivalents is substantially below 100 mg/dL consider aggressive lipid-lowering strategies in this group. With the advent of more powerful statins, combination therapy, and newer nonstatin agents, you can...

Descripción completa

Publicado en:Patient Care (Print) Vol. 40; no. 2; pp. 26 - 35
Autor principal: Ansell BJ
Formato: case study pictorial questionnaire/scale tables/charts Journal Article
Publicado: MJH Life Sciences Feb2006
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106353576&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106353576
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0031305X
        PAC
      jtl: Patient Care (Print)
      issn: 0031305X
      maglogo: N
    pubinfo:
      dt: Feb2006
      vid: 40
      iid: 2
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        106353576
        106353576
        2009298264
        106353576
      ppf: 26
      ppct: 9
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: How to get your high-risk patients to the new NCEP goals.
      aug:
        au: Ansell BJ
        affil: Associate Clinical Professor of Medicine, University of California, Los Angeles
      sug:
        subj:
          Hypercholesterolemia Drug Therapy
          Hypercholesterolemia Prevention and Control
          Patient Education
          Aged
          Algorithms Utilization
          Clinical Assessment Tools
          Male
          Reference Values
          Aged: 65+ years
          Male
      ab: Now that the optimal LDL-cholesterol level for patients with coronary heart disease or its risk equivalents is substantially below 100 mg/dL consider aggressive lipid-lowering strategies in this group. With the advent of more powerful statins, combination therapy, and newer nonstatin agents, you can help a significantly greater proportion of your patients attain their lipid goals.
      pubtype: Academic Journal
      doctype:
        case study
        pictorial
        questionnaire/scale
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N